Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
20 August 2018 |
Main ID: |
ChiCTR1800017560 |
Date of registration:
|
2018-08-04 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Association of serum D-dimer and PDF with the BP severity
|
Scientific title:
|
Association of serum D-dimer and PDF with the BP severity |
Date of first enrolment:
|
2018-08-31 |
Target sample size:
|
Target condition:160;Difficult condition:0 |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=29364 |
Study type:
|
Diagnostic test |
Study design:
|
Diagnostic test for accuracy
|
Phase:
|
Diagnostic New Technique Clincal Study
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Xia Yumin
|
Address:
|
157 Xiwu Road, Xincheng District, Xi'an, Shaanxi, China
|
Telephone:
|
+86 15619371713 |
Email:
|
xiayumin1202@163.com |
Affiliation:
|
the Second Affiliated Hospital, Xi'an Jiaotong University |
|
Name:
|
Liu Yale
|
Address:
|
157 Xiwu Road, Xincheng District, Xi'an, Shaanxi, China
|
Telephone:
|
+86 18209261277 |
Email:
|
liuyale114@163.com |
Affiliation:
|
the Second Affiliated Hospital, Xi'an Jiaotong University |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Aged 18-90 years old male and female;
2. BP was diagnosed based on clinic and pathology;
3. coagulation six indices were conducted after admission;
4. Informed admission consent was signed when they admitted.
Exclusion criteria: Patients with cardiopulmonary and peripheral vascular diseases, acute and chronic inflammation, trauma, pregnancy and other malignant tumors that affect the function of the coagulation system.
Age minimum:
18
Age maximum:
90
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Bullous pemphigoid
|
Intervention(s)
|
Gold Standard:Clinical outcome;Index test:D-dimer, FDP, anti-BP180 IgG;
|
Primary Outcome(s)
|
D-dimer, FDP, anti-BP180 IgG;SPE, SEN, ACC, AUC of ROC;
|
Source(s) of Monetary Support
|
National natural Fundation
|
Ethics review
|
Status: Approved
Approval date: 03/03/2015
Contact:
Yang Dechang
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|